exhibit 10. 1 master services agreement this master services agreement ( the “ agreement ” ) is entered into to be effective as of january 1, 2016 ( the “ effective date ” ), by and between inovalon, inc., a delaware corporation, for its own behalf and on behalf of each of its affiliates ( collectively “ inovalon ” ), and triple - s advantage, inc., administered by triple - s advantage solutions, inc. ( “ tsa ” ) ( collectively, “ client ” ). recitals a. inovalon is a provider of data - driven solutions for the assessment and improvement of clinical and quality outcomes, care management, and financial performance across the healthcare community. amongst other solution suites, inovalon provides a suite of technology - enabled solutions designed to enhance clients ’ member disease and co - morbidity identification, encounter facilitation, assessment, data accuracy, documentation, care coordination, decision support, and disease management so as to achieve a broader set of goals inclusive of improving quality of care, clinical outcomes, cost reduction, data accuracy improvement, and clarification of disease and co - morbidity, capitated, and risk - adjusted reimbursement information on behalf of client. a. inovalon is a provider of data - driven solutions for the assessment and improvement of clinical and quality outcomes, care management, and financial performance across the healthcare community. amongst other solution suites, inovalon provides a suite of technology - enabled solutions designed to enhance clients ’ member disease and co - morbidity identification, encounter facilitation, assessment, data accuracy, documentation, care coordination, decision support, and disease management so as to achieve a broader set of goals inclusive of improving quality of care, clinical outcomes, cost reduction, data accuracy improvement, and clarification of disease and co - morbidity, capitated, and risk - adjusted reimbursement information on behalf of client. a. inovalon is a provider of data - driven solutions for the assessment and improvement of clinical and quality outcomes, care management, and financial performance across the healthcare community. amongst other solution suites, inovalon provides a suite of technology - enabled solutions designed to enhance clients ’ member disease and co - morbidity identification, encounter facilitation, assessment, data accuracy, documentation, care coordination, decision support, and disease management so as to achieve a broader set of goals inclusive of improving quality of care